Bone marrow-derived mesenchymal stem cells (BM-MSCs) from healthy and autoimmune disease patients reduce in vitro the proliferation of anti-CD3Õ-stimulated autologous and allogeneic lymphocytes

Rhodri Ceredig

Bone marrow-derived mesenchymal stem cells (BM-MSCs) from healthy and autoimmune disease patients reduce in vitro the proliferation of anti-CD3Õ-stimulated autologous and allogeneic lymphocytes

Rhodri Ceredig

Medicine

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

Original language	English (Ireland)
Journal	Rheumatology
Volume	46
Issue number	4
Publication status	Published - 1 Jan 2008

Authors (Note for portal: view the doc link for the full list of authors)

Authors
C. C. Bocelli-Tyndall, L. Bracci, G. Spagnoli , A. Braccini, M. Bouchenaki, Rh. Ceredig , V. Pistoia, I. Martin and A. Tyndall.

Cite this

@article{8e0dd31c4f3e411e99a708ee723a761f,

title = "Bone marrow-derived mesenchymal stem cells (BM-MSCs) from healthy and autoimmune disease patients reduce in vitro the proliferation of anti-CD3{\~O}-stimulated autologous and allogeneic lymphocytes",

author = "Rhodri Ceredig",

year = "2008",

month = jan,

day = "1",

language = "English (Ireland)",

volume = "46",

journal = "Rheumatology",

publisher = "Oxford University Press, Oxford",

number = "4",

}